Prevalence patterns and genotypes of GB virus C/hepatitis G virus among imprisoned intravenous drug users

Journal of Medical Virology

Volumn 56, Issue 3, 1998, Pages 246-252

  Anastassopoulou, Cleo G ^a   Paraskevis, Dimitrios ^a   Sypsa, Vassiliki ^a   Psichogiou, Mina ^a   Katsoulidou, Antigoni ^a   Tassopoulos, Nicolaos ^b   Skoutelis, Athanassios ^c   Malliori, Meni ^d   Hatzakis, Angelos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Western Attica General Hospital   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

5' UTR; RT PCR; Viral hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; VIRUS RNA;

ACUTE HEPATITIS; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; GENOTYPE; GREECE; HEPATITIS G VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRISONER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROPREVALENCE; VIREMIA; VIRUS GENOME; VIRUS TRANSMISSION;

5' UNTRANSLATED REGIONS; ADULT; AGED; ALANINE TRANSAMINASE; FLAVIVIRIDAE; GENOTYPE; GREECE; HEPATITIS ANTIBODIES; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PREVALENCE; PRISONERS; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE ABUSE, INTRAVENOUS;

GB VIRUS C/HEPATITIS G VIRUS; HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0031694028     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199811)56:3<246::AID-JMV12>3.0.CO;2-C     Document Type: Article

References (26)

1. Aikawa T, Sugai Y, Okamoto H (1996): Hepatitis G infection in drug abusers with chronic hepatitis C. New England Journal of Medicine 334:195-196.
2. Alter HJ (1996): The cloning and clinical implications of HGV and HGBV-C. New England Journal of Medicine 334:1536-1537.
3. Diamantis I, Bassetti S, Erb P, Ladewig D, Gyr K, Battegay M (1997): High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts. Journal of Hepatology 26:794-797.
4. Dille BJ, Surowy TK, Gutierrez RA, Coleman PF, Knigge MF, Carrick RJ, Aach RD, Hollinger FB, Stevens CE, Barbosa LH, Nemo GJ, Mosley JW, Dawson GJ, Mushahwar IK (1997): An ELISA for detection of antibodies to the E2 protein of GB virus C. Journal of Infectious Diseases 175:458-461.
5. Erker JC, Simons JN, Muerhoff AS, Leary TP, Chalmers M, Desai SM, Mushahwar IK (1996): Molecular cloning and characterization of a GB virus C isolate from a patient with nonA-E hepatitis. Journal of General Virology 77:2713-2720.
6. Felsenstein J (1993): "PHYLIP: Phytogeny Inference Package, Version 3.5." Seattle: Department of Genetics, University of Washington.
7. Hadziyannis S, Wages J, Kim J-P, Karayiannis P, Hess G, Piatak M, Lifson J, Vrettou H, Horsch A, Foung S, Thomas H-C (1995): Frequency of viremia with a new hepatitis virus (HGV) in patients with liver disease and in groups at high risk of exposure to blood and blood products. Journal of Hepatology [Suppl] 23:78 [abstract].
8. Higgins DG, Sharp PM (1989): Description of the method used in CLUSTAL. Computer Applications in the Biosciences 5:151-153.
9. Kimura M (1980): A simple method for estimating evolutionary rates of base substitution through comparative studies of nucleotide sequences. Journal of Molecular Evolution 16:111-120.
10. Kwok S, Higuchi R (1989): Avoiding false positives with PCR. Nature 339:237-238.
11. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Desai SM, Mushahwar IK (1996): The sequence and genomic organization of GBV-C: A novel member of the Flaviviridae associated with human nonA-E hepatitis. Journal of Medical Virology 48:60-67.
12. Linnen J, Wages J Jr, Zhang-Keck Z, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayiannis P, Fung K, Nakatsuji Y, Shih JW, Young L, Piatak M Jr, Hoover C, Fernandez J, Chen S, Zou J, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Foung SKJ, Thomas H, Bradley D, Margolis H, Kim JP (1996): Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 271:505-508.
13. Muerhoff SA, Simons JN, Leary TP, Erker JC, Chalmers ML, Pilot-Matias TJ, Dawson GJ, Desai SM, Mushahwar IK (1996): Sequence heterogeneity within the 5′-terminal region of the hepatitis GB virus C genome and evidence for genotypes. Journal of Hepatology 25:379-384.
14. Muerhoff SA, Smith DB, Leary TP, Erker JC, Desai SM, Mushahwar IK (1997): Identification of GB virus C variants by phylogenetic analysis of 5′-untranslated and coding region sequences. Journal of Virology 71:6501-6508.
15. Page, RDM (1996): TREEVIEW: An application to display phylogenetic trees on personal computers. Computer Applications in the Biosciences 12:357.
16. Pilot-Matias TJ, Carrick RJ, Coleman PF, Leary TP, Surowy TK, Simons JN, Muerhoff AS, Buijk SL, Chalmers ML, Dawson GJ, Desai SM, Mushahwar IK (1996): Expression of the GB virus C E2 glycoprotein using the Semliki forest virus vector system and its utility as a serologic marker. Virology 225:282-292.
17. Saitou N, Nei M (1987): The neighbor-joining method: A new method for reconstructing phylogenetic trees. Molecular Biological Evolution 4:406-425.
18. Schlueter V, Schmolke S, Stark K, Hess G, Ofenloch-Haehnle B, Engel AM (1996): Reverse transcription-PCR detection of hepatitis G virus. Journal of Clinical Microbiology 34:2660-2664.
19. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK (1995): Isolation of novel virus-like sequences associated with human hepatitis. Nature Medicine 1:564-569.
20. Simons JN, Desai SM, Mushahwar IK (1996): The GB viruses: Isolation, characterization, diagnosis and epidemiology. Viral Hepatitis Reviews 2:229-246.
21. Stark K, Bienzle U, Hess G, Engel AM, Hegenscheid B, Schlueter V (1996): Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors. Journal of Infectious Diseases 174:1320-1323.
22. Tacke M, Kiyosawa K, Stark K, Schlueter V, Ofenloch-Haehnle B, Hess G, Engel AM (1997a): Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 349:318-320.
23. Tacke M, Schmolke S, Schlueter V, Sauleda S, Esteban JI, Tanaka E, Kiyosawa K, Alter H, Schmitt U, Hess G, Ofenloch-Haehnle B, Engel AM (1997b): Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 26:1626-1633.
24. Tanaka E, Alter HJ, Nakatsuji Y, Shih W-K, Kim JP, Matsumoto A, Kobayashi M, Kiyosawa K (1996): Effect of hepatitis G virus infection on chronic hepatitis C. Annals of Internal Medicine 125:740-743.
25. Thomas DL, Nakatsuji Y, Shih JW, Alter HJ, Nelson KE, Astemborski JA, Lyles CM, Vlahov D (1997): Persistence and clinical significance of hepatitis G virus infections in injecting drug users. Journal of Infectious Diseases 176:586-592.
26. Zehender G, De Maddalena C, Bianchi Bosisio A, Gianotto M, Santambrogio S, Moroni M, Galli M (1998): Prevalence of hepatitis G virus RNA in human immunodeficiency virus type 1-positive intravenous drug users. Journal of Human Virology 1:96-100.